Preconception Care of Diabetes: Glycemic Control Prevents Congenital Anomalies

JAMA: The Journal of the American Medical Association

Volumn 265, Issue 6, 1991, Pages 731-736

  Kitzmiller, John L ^a   Gavin, Laurence A ^a   Gin, Gary D ^b   Jovanovic Peterson, Lois ^b   Main, Elliott K ^b   Zigrang, William D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO DEVELOPMENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL;

ABNORMALITIES; ADULT; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; FERTILIZATION; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; HYPERGLYCEMIA; PATIENT EDUCATION; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE; SUPPORT, NON-U.S. GOV'T;

EID: 0025965216     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1991.03460060063025     Document Type: Article

References (38)

1. Kitzmiller JL, Cloherty JP, Younger MD, et al. Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol. 1978;131:560-580.
2. Gabbe SG. Congenital malformations in infants of diabetic mothers. Obstet Gynecol Surv. 1977; 32:125-131.
3. Cousins L. Congenital anomalies among infants of diabetic mothers: etiology, prevention, diagnosis. Am J Obstet Gynecol. 1983;147:333-338.
4. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes. 1979;28:292-293.
5. Pedersen J. The Pregnant Diabetic and Her Newborn. 2nd ed. Baltimore, Md: Williams & Wilkins; 1977.
6. Karlsson K, Kjellmer I. The outcome of diabetic pregnancies in relation to the mother’s blood sugar level. Am J Obstet Gynecol. 1972;112:213-220.
7. Leslie RDG, Pyke DA, John PN, White JM. Haemoglobin A1 in diabetic pregnancy. Lancet. 1978;2:958-959.
8. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331-1334.
9. Ylinen K, Aula P, Stenman U-H, et al. Risk of minor and major fetal malformations in diabetes with high haemoglobin A1c values in early pregnancy. BMJ. 1984;289:345-346.
10. Key TC, Guiffrida R, Moore TR. Predictive value of early pregnancy glycohemoglobin in the insulin treated diabetic patient. Am J Obstet Gynecol. 1987;156:1096-1100.
11. Miodovnik M, Mimouni F, Dignam PS. Major malformations in infants of IDDM women: vasculopathy and early first-trimester poor glycemic control. Diabetes Care. 1988;11:713-718.
12. Greene MF, Hare JW, Cloherty JP, et al. Firsttrimester hemoglobin A1 and risk of major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39:225-231.
13. Mills JL, Knopp RH, Simpson JL, et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med. 1988;318:671-676.
14. Hare JW, White P. Gestational diabetes and the White classification. Diabetes Care. 1980;3: 294-295.
15. Piaquadio K, Hollingsworth D, Murphy H. Fetal malformation following first trimester use of oral hypoglycemic agents. Diabetes. 1990;39(suppl 1):123A.
16. Kitzmiller JL, Gavin LA, Gin GD, et al. Managing diabetes and pregnancy. Curr Probl Obstet Gynecol Fertil. 1988;11:107-167.
17. Kitzmiller JL, Younger DM, Hare J, et al. Continuous subcutaneous infusion therapy during early pregnancy. Obstet Gynecol. 1985;66:1177-1182.
18. Sosenko JM, Kitzmiller JL, Fluckiger R, Loos SWH, Younger D, Gabbay KH. Umbilical cord glycosylated hemoglobin in infants of diabetic mothers: relationships to neonatal hypoglycemic, macrosomia, and cord serum C-peptide. Diabetes Care. 1982;5:566-570.
19. Fuhrmann K, Reiher H, Semmler K, et al. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care. 1983;6:219-223.
20. Goldman JA, Dicker D, Feldberg D, et al. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am J Obstet Gynecol. 1986;155:293-297.
21. Damm P, Mølsted-Pedersen L. Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol. 1989;161:1163-1167.
22. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988;319:1617-1623.
23. Crockroft DL, Coppola PT. Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratology. 1977;16:141-146.
24. Sadler TW. Effects of maternal diabetes on early embryogenesis, II: hyperglycemia-induced exencephaly. Teratology. 1980;21:349-356.
25. Eriksson UJ. Importance of genetic predisposition and maternal environment for the occurrence of congenital malformation in offspring of diabetic rats. Teratology. 1988;37:365-374.
26. Freinkel N, Cockroft DL, Lewis NJ, et al. Fuelmediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture. Am J Clin Nutr. 1986;44:986-995.
27. Goldman AS, Baker L, Piddington R, et al. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci U S A. 1985;82:8227-8231.
28. Pinter E, Reece EA, Leranth C, et al. Arachidonic acid prevents hyperglycemia associated yolk sac damage and embryopathy. Am J Obstet Gynecol. 1986;155:691-702.
29. Hod M, Star S, Passonneau JV, et al. Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Comm. 1986;140:974-980.
30. Sussman I, Matschinsky FM. Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes. 1988;37:974-981.
31. Horton WE Jr, Sadler TW. Effects of maternal diabetes on early embryogenesis: alterations in morphogenesis produced by the ketone body, β-hydroxybutyrate. Diabetes. 1983;32:610-616.
32. Hunter ES III, Sadler TW, Wynn RE. A potential mechanism of DL-β-hydroxybutyrate-induced malformations in mouse embryos. Am J Physiol. 1987;253:E72-E80.
33. Sadler TW, Hunter ES III, Wynn RE, Phillips LS. Evidence of multifactorial origin of diabetesinduced embryopathies. Diabetes. 1989;38:70-74.
34. Freinkel N, Lewis NJ, Akazawa S, et al. The honeybee syndrome: implications of the teratogenicity of mannose in rat-embryo. N Engl J Med. 1984;310:223-230.
35. Buchanan TA, Schemmer JK, Freinkel N. Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat. J Clin Invest. 1986;78:643-649.
36. Akazawa M, Akazawa S, Hashimoto M, et al. Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes. 1989;38:1573-1578.
37. Buchanan TA, Sipos GF. Lack of teratogenic effect of brief maternal insulin-induced hypoglycemia in rats during late neurulation. Diabetes. 1989;38:1063-1066.
38. Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can pregnancy care of diabetic women reduce the risk of abnormal babies? BMJ. 1990;301:1070-1074.